Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 100 of 1,261
  1. US 12064398

    Parenteral formulations

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  2. US 12064473

    Cancer vaccines targeting Survivin and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  3. US 12064411

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  4. US 12064472

    Southern cattle tick vaccine product

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  5. US 12065428

    Anti-viral compounds

    Aligos Therapeutics, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  6. US 12064502

    Peptide exhibiting wrinkle-improving activity and uses thereof

    CAREGEN CO., LTD. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  7. US 12064433

    Pyridone A2R antagonists

    Arcus Biosciences, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  8. US 12065412

    CFTR regulators and methods of use thereof

    The Regents of the University of California · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  9. UY 40646

    DERIVADOS DE N-ÓXIDO DE ETIL-SULFONA/SULFOXIMINA-PIRIDINA SUSTITUIDOS CON CICLOPROPIL-(HETERO)ARILO

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Aug 15, 2024 · Expires Aug 10, 2044

    granted
  10. UY 40645

    DERIVADOS DE ETIL-SULFOXIMA-PIRIDINA SUSTITUIDOS CON CICLOPROPIL-(HETERO)ARILO

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Aug 15, 2024 · Expires Aug 10, 2044

    granted
  11. UY 40647

    DERIVADOS DE ETILSULFONA/SULFOXIMINA-PIRIDINA SUSTITUIDOS CON TETRAZOL

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Aug 15, 2024 · Expires Aug 10, 2044

    granted
  12. US 12060327

    Psychotropic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  13. US 12059437

    Methods and compositions for hematopoietic stem cell mobilization

    The Regents of the University of California · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  14. US 12059413

    Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  15. US 12059474

    Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins

    The Board of Regents of the University of Texas System · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  16. US 12060428

    Anti-IL36R antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  17. US 12060346

    Inhibitors of APOL1 and methods of using same

    Vertex Pharmaceuticals Incorporated · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  18. US 12060398

    Fibrous proteinaceous networks and methods of use thereof

    Northwestern University · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  19. US 12059400

    Medical compound

    VERA SALUS RICERCA S.R.L. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  20. US 12059471

    Complex

    UNITED IMMUNITY, CO., LTD. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  21. US 12060362

    Inhibitors of glucose transporters (GLUTs)

    Lead Discovery Center GmbH · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  22. US 12060419

    CD79A chimeric antigen receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  23. US 12060382

    Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole

    Takeda Pharmaceutical Company Limited · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  24. US 12059468

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.